Evaluation of End of Life Quality of Care

Evaluation of the Relevance Indicators of Quality of Care for Dying Patients Based on Analysis of Care and Follow-up Course of the Leonetti Law. EFIQUAVIE Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03775304

Acronym

EFIQUAVIE

Enrollment

997

Registered

2018-12-13

Start date

2011-01-01

Completion date

2015-12-15

Last updated

2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End of Life Care, Neoplasm Malignant, Quality of Life

Brief summary

The study uses a mixed method study to evaluate wether the use of the indicators of the Quality of end-of-life cancer care, developed by Earle et al \[Earle JCO 2003; DOI: 10.1200/JCO.2003.03.059\] would be relevant and measurable in France. The qualitative part of study was designed to investigate the representations of quality by face-to face interviews with family carer of recently deceased cancer patients, and with their oncologists, and nurses. The quantitative part of the study, consisted in a decedents case series analysis, diagnosed with advanced cancer and followed up in 5 centers. Data on trajectory of care were collected from different complementary sources associating national mortality data, hospital activity data, and health records. The study was approved by the French data protection authority (CNIL) number 611273.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Patients aged ≥ 18, * diagnosed with advanced cancer (recruited from hospital activity data, by a stay with a ICD code of metastatic cancer between Oct 1st, 2009 and Dec 31, 2010) * deceased between, Jan 1st, 2010 and Dec 31, 2010 (vital status identified either from hospital activity data, or from national mortality statistics)

Exclusion criteria

* diagnosis with non solid tumor (haematology) * age \< 18

Design outcomes

Primary

Measure	Time frame
Use of emergency services within last 30 days before death	Through study completion, up to 1 year

Secondary

Measure	Time frame
Patients received chemotherapy in the last 14 days of life	Through study completion, up to 1 year
Location of death	Through study completion, up to 1 year
Among patients who died in palliative care unit, those who died within 3 days after admission	Through study completion, up to 1 year
Admission in intensive care unit within last 30 days before death	Through study completion, up to 1 year
Among patients with pain relief opioid treatment, those with combined short term and long acting opioid orders	Through study completion, up to 1 year

Countries

France

Outcome results